- Home
- SUUN vs TENX Comparison
SUUN vs TENX Comparison
Compare SUUN & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUUN | TENX |
|---|---|---|
| Founded | 2013 | 1967 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.2M | 56.2M |
| IPO Year | 2024 | 2001 |
Fundamental Metrics
Financial Performance| Metric | SUUN | TENX |
|---|---|---|
| Price | $0.70 | $13.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $5.00 | ★ $22.50 |
| AVG Volume (30 Days) | ★ 969.5K | 291.3K |
| Earning Date | 01-01-0001 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $112.68 | N/A |
| Revenue Next Year | $1.75 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $4.64 |
| 52 Week High | $4.75 | $18.38 |
Technical Indicators
Market Signals| Indicator | SUUN | TENX |
|---|---|---|
| Relative Strength Index (RSI) | 33.52 | 60.40 |
| Support Level | N/A | $11.63 |
| Resistance Level | $0.90 | $18.38 |
| Average True Range (ATR) | 0.07 | 1.08 |
| MACD | 0.01 | 0.34 |
| Stochastic Oscillator | 23.32 | 73.71 |
Price Performance
Historical ComparisonAbout SUUN SolarBank Corporation
PowerBank Corp is an independent renewable and clean energy project developer, power producer, and asset operator in Canada and the United States, with the majority of its revenue coming from the United States. The Company operates through two reportable segments: Development and EPC, which involves the development and construction of solar photovoltaic power projects, and IPP Production, which includes the operation of solar power and battery energy storage systems. Corporate and other activities cover operation, maintenance, and repairs. The majority of revenue is generated from the Development and EPC segment.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.